// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
The use of environmentally friendly and energy saving LED lamps are cost-effective especially for villages with a limited budget.
For ordinary subscribers, who consume up to 10,000 cub.m. of gas per month, the PSRC set the tariff at AMD139 (approx. $0,29) per cub.m.
The recent heists in Europe and Asia were run from central, remote command centers, enabling criminals to target large numbers of machines.
Bilyan is charged with killing Gagik Mkrtchyan, he has pleaded not guilty, and we are going to prove he has nothing to do with the murder.
Partner news